Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 5,897,900
- Avg volume
- 664,052
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 100%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 814 786 8849
- Website
- https://halberdcorporation.com
- Address
- PO Box 25, Jackson Center, United States
Latest news
No headlines yet.
